GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (FRA:0V0) » Definitions » EPS (Diluted)

Vimian Group AB (FRA:0V0) EPS (Diluted) : €0.04 (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB EPS (Diluted)?

Vimian Group AB's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was €0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.04.

Vimian Group AB's EPS (Basic) for the three months ended in Dec. 2024 was €0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.04.

Vimian Group AB's EPS without NRI for the three months ended in Dec. 2024 was €0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was €0.04.

During the past 12 months, Vimian Group AB's average EPS without NRIGrowth Rate was 105.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 17.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Vimian Group AB's highest 3-Year average EPS without NRI Growth Rate was 315.70% per year. The lowest was -78.50% per year. And the median was 17.70% per year.


Vimian Group AB EPS (Diluted) Historical Data

The historical data trend for Vimian Group AB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB EPS (Diluted) Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Diluted)
Get a 7-Day Free Trial 2.06 0.02 -0.02 0.02 0.04

Vimian Group AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.01 0.01 - 0.02

Competitive Comparison of Vimian Group AB's EPS (Diluted)

For the Diagnostics & Research subindustry, Vimian Group AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's PE Ratio falls into.


;
;

Vimian Group AB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Vimian Group AB's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(18.5-0)/504.496
=0.04

Vimian Group AB's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(12.2-0)/524.564
=0.02

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB  (FRA:0V0) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vimian Group AB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines